Repository logo
  • English
  • Srpski (lat)
  • Српски
Log In
Have you forgotten your password?
  1. Home
  2. Browse by Author

Browsing by Author "Dweck, Marc R (12783691400)"

Filter results by typing the first few letters
Now showing 1 - 4 of 4
  • Results Per Page
  • Sort Options
  • Loading...
    Thumbnail Image
    Some of the metrics are blocked by your 
    consent settings
    Publication
    EACVI survey on burnout amongst cardiac imaging specialists during the 2019 coronavirus disease pandemic
    (2022)
    Joshi, Shruti S. (57195225634)
    ;
    Stankovic, Ivan (57197589922)
    ;
    Demirkiran, Ahmet (57185410200)
    ;
    Haugaa, Kristina (24733615600)
    ;
    Maurovich-Horvat, Pal (57221915836)
    ;
    Popescu, Bogdan A (37005664700)
    ;
    Cosyns, Bernard (57202595662)
    ;
    Edvardsen, Thor (6603263370)
    ;
    Petersen, Steffen E (35430477200)
    ;
    Carvalho, Ricardo Fontes (57210811139)
    ;
    Cameli, Matteo (36906722500)
    ;
    Dweck, Marc R (12783691400)
    Aims: The European Association of Cardiovascular Imaging Scientific Initiatives Committee conducted a global survey to evaluate the impact of the 2019 coronavirus disease (COVID-19) pandemic on the mental well-being of cardiac imaging specialists. Methods and results: In a prospective international survey performed between 23 July 2021 and 31 August 2021, we assessed the mental well-being of cardiac imaging specialists ∼18 months into the COVID-19 pandemic. One-hundred-and-twenty-five cardiac imaging specialists from 34 countries responded to the survey. More than half described feeling anxious during the pandemic, 34% felt melancholic, 27% felt fearful, and 23% respondents felt lonely. A quarter of respondents had increased their alcohol intake and more than half reported difficulties in sleeping. Two-thirds of respondents described worsening features of burnout during the past 18 months, 44% considered quitting their job. One in twenty respondents had experienced suicidal ideation during the pandemic. Despite these important issues, the majority of participants (57%) reported having no access to any formal mental health support at work. Conclusion: The survey has highlighted important issues regarding the mental well-being of cardiac imaging specialists during the COVID-19 pandemic. This is a major issue in our sub-specialty, which requires urgent action and prioritization so that we can improve the mental health of cardiovascular imaging specialists. © 2022 Published on behalf of the European Society of Cardiology. All rights reserved.
  • Loading...
    Thumbnail Image
    Some of the metrics are blocked by your 
    consent settings
    Publication
    EACVI survey on hypertrophic cardiomyopathy
    (2022)
    Podlesnikar, Tomaz (57188636569)
    ;
    Cardim, Nuno (7004229183)
    ;
    Ajmone Marsan, Nina (23035780700)
    ;
    D'Andrea, Antonello (55612687400)
    ;
    Cameli, Matteo (36906722500)
    ;
    Popescu, Bogdan A (37005664700)
    ;
    Schulz-Menger, Jeanette (6701382131)
    ;
    Stankovic, Ivan (57197589922)
    ;
    Toplisek, Janez (56085208200)
    ;
    Maurer, Gerald (55606327600)
    ;
    Haugaa, Kristina H (24733615600)
    ;
    Dweck, Marc R (12783691400)
    Aims: The European Association of Cardiovascular Imaging (EACVI) Scientific Initiatives Committee performed a global survey to evaluate current practice for the assessment and management of patients with hypertrophic cardiomyopathy (HCM). Methods and results: A total of 213 centres from 38 different countries (87% European) responded to the survey. One hundred twenty-one (57%) centres followed HCM patients in a general cardiology outpatient clinic and 85 (40%) centres in a specialized HCM/cardiomyopathy clinic. While echocardiography was the primary imaging modality, cardiovascular magnetic resonance (CMR) has become an important complementary tool. Cardiac anatomy, left ventricular (LV) systolic, and diastolic function were assessed according to current European guidelines and recommendations. To evaluate LV obstruction, 49% of the centres performed bedside provocation manoeuvres in every patient and 55% of the centres used exercise stress echocardiography. The majority of centres used the 5-year risk assessment of sudden cardiac death (SCD) calculated with the HCM Risk-SCD score. However, 34% of the centres also used extensive non-infarct late gadolinium enhancement on CMR and 27% the presence of LV apical aneurysm to help select patients for primary prevention implantable cardioverter-defibrillator therapy. Ninety-nine percent of the responding centres performed regular imaging follow-up of HCM patients. Conclusion: Most centres followed European guidelines and recommendations for the diagnosis and management of patients with HCM. The importance of bedside provocation manoeuvres and exercise stress echocardiography to diagnose LV outflow obstruction requires emphasis. Additional risk markers for SCD are used in many centres and might indicate the need for an update of current European recommendations. © 2021 Published on behalf of the European Society of Cardiology. All rights reserved.
  • Loading...
    Thumbnail Image
    Some of the metrics are blocked by your 
    consent settings
    Publication
    EACVI survey on the evaluation of left ventricular diastolic function
    (2021)
    Sitges, Marta (7006509888)
    ;
    Ajmone Marsan, Nina (23035780700)
    ;
    Cameli, Matteo (36906722500)
    ;
    D'Andrea, Antonello (55612687400)
    ;
    Carvalho, Ricardo Fontes (57210811139)
    ;
    Holte, Espen (23024605700)
    ;
    Michalski, Blazej (14527627100)
    ;
    Podlesnikar, Tomaz (57188636569)
    ;
    Popescu, Bogdan A (37005664700)
    ;
    Schulz-Menger, Jeanette (6701382131)
    ;
    Stankovic, Ivan (57197589922)
    ;
    Haugaa, Kristina H (24733615600)
    ;
    Dweck, Marc R (12783691400)
    Aims: The aim of this study is to analyse how current recommendations on left ventricular (LV) diastolic function assessment have been adopted. Identifying potential discrepancies between recommendations and everyday clinical practice would enable us to better understand and address the remaining challenges in this controversial and complex field. Methods and results: A total of 93 centres, mainly from tertiary care settings, responded to the survey. More than three-quarters (77%) of centres follow the 2016 ASE/EACVI recommendations for LV diastolic function evaluation in patients with preserved ejection fraction based upon e′, E/e′, tricuspid regurgitation velocity, and left atrial (LA) volume. These recommendations were generally preferred to the previous 2009 version. Many centres also consider strain assessments in the LV (48%) and left atrium (53%) as well as diastolic stress echocardiography (33%) to be useful as additional assessments of LV diastolic function. Echocardiographic assessments of LV diastolic function were used frequently to guide therapy in 72% of centres. Conclusion: There is widespread adoption of current recommendation on the evaluation of LV diastolic function and these are frequently used to guide patient management. Many centres now also consider LV and LA strain assessments useful in the clinical assessment of diastolic function. These may be considered in future recommendations. © 2021 The Author(s).
  • Loading...
    Thumbnail Image
    Some of the metrics are blocked by your 
    consent settings
    Publication
    The EACVI survey on cardiac imaging in cardio-oncology
    (2021)
    Stankovic, Ivan (57197589922)
    ;
    Dweck, Marc R (12783691400)
    ;
    Marsan, Nina Ajmone (23035780700)
    ;
    Bergler-Klein, Jutta (56019537300)
    ;
    Holte, Espen (23024605700)
    ;
    Manka, Robert (8839069800)
    ;
    Schulz-Menger, Jeanette (6701382131)
    ;
    Sitges, Marta (7006509888)
    ;
    Haugaa, Kristina H (24733615600)
    Early and late cardiovascular (CV) toxicities related to many cancer treatments may complicate the clinical course of patients, offsetting therapeutic benefits, and altering prognosis. The early detection, monitoring, and treatment of cardiotoxicity have therefore become essential parts of cancer patient care. CV imaging is a cornerstone of every cardio-oncology unit, but its use may vary across Europe because of the non-uniform availability of advanced imaging techniques and differences in the organization and logistics of cardio-oncology services. The purpose of this EACVI survey in cardio-oncology is to obtain real-world data on the current usage of cardiac imaging in cancer patients. Data from 104 centres and 35 different countries confirmed that cardiac imaging plays a pivotal role in the detection and monitoring of cardiac toxicity in oncology patients in Europe and beyond. However, it also revealed gaps between guidelines recommendations and everyday clinical practice, highlighting some of the challenges that need to be overcome in this rapidly advancing field. © 2020 Published on behalf of the European Society of Cardiology. All rights reserved.

Built with DSpace-CRIS software - Extension maintained and optimized by 4Science

  • Privacy policy
  • End User Agreement
  • Send Feedback